Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo | Citedby Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo

Mol Cancer Ther (2022) 21 (3): 460–470.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Mathematical Modeling of Oncolytic Virus Therapy Reveals Role of the Immune Response

Ela Guo
Hana M. Dobrovolny

Viruses (2023) 15 (9): 1812.

Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment

Ivan D. Osipov
Valeriia A. Vasikhovskaia
Daria S. Zabelina
Sergei S. Kutseikin
Antonina A. Grazhdantseva
Galina V. Kochneva
Julia Davydova
Sergey V. Netesov
Margarita V. Romanenko

Viruses (2023) 15 (1): 182.

Optimal delivery of RNA interference by viral vectors for cancer therapy

Boaz Wong
Rayanna Birtch
Reza Rezaei
Taylor Jamieson
Mathieu J.F. Crupi
Jean-Simon Diallo
Carolina S. Ilkow

Molecular Therapy (2023) 31 (11): 3127.

An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer

Maryum Nisar
Rehan Zafar Paracha
Sidra Adil
Sumair Naseem Qureshi
Hussnain Ahmed Janjua

Frontiers in Oncology (2022) 12

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo

Jie Tian
Zhili Xu
Rituparna Moitra
Donna J. Palmer
Philip Ng
Andrew P. Byrnes
Dmitry Shayakhmetov

PLOS Pathogens (2022) 18 (9): e1010859.

HEHR: Homing Endonuclease-Mediated Homologous Recombination for Efficient Adenovirus Genome Engineering

Katrin Schröer
Fatima Arakrak
Annika Bremke
Anja Ehrhardt
Wenli Zhang

Genes (2022) 13 (11): 2129.